ASX:SPL is an Australian biotechnology company that specializes in the development of innovative products for pharmaceutical, life science, and other industries. The company's proprietary technology platform, DEP, enhances the effectiveness and safety of existing drugs and enables the development of new drug candidates. As an Aussie stock, SPL is of interest to traders and investors who are looking for opportunities in the biotech sector. Join our forum to discuss ASX:SPL and other Australian stocks with fellow traders.